Sulphinpyrazone vs placebo
Complications (up to 3 months) · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft
1 finding from 1 review
- Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts 2021 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedLow